PARP INHIBITOR
Clinical trials for PARP INHIBITOR explained in plain language.
Never miss a new study
Get alerted when new PARP INHIBITOR trials appear
Sign up with your email to follow new studies for PARP INHIBITOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for incurable brain cancer: drug combo shows promise
Disease control OngoingThis study tests whether adding the drug olaparib to standard radiation and chemotherapy can help people with aggressive, inoperable brain tumors live longer. About 91 participants will receive the combination treatment. The goal is to find the best dose and see if it improves su…
Matched conditions: PARP INHIBITOR
Phase: PHASE1, PHASE2 • Sponsor: Centre Francois Baclesse • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
Lung cancer clue: DNA repair flaw may guide future treatments
Knowledge-focused OngoingThis study examines 100 people with a certain type of advanced lung cancer (EGFR-mutated NSCLC) to see how often they have a DNA repair problem called HRD. Researchers will look at tumor samples and medical records to find links between HRD and how the cancer behaves. The goal is…
Matched conditions: PARP INHIBITOR
Sponsor: IRCCS San Raffaele • Aim: Knowledge-focused
Last updated May 17, 2026 11:34 UTC